Almatica Pharma
- Company typePrivate
- Founded2009
- HeadquartersMorristown, United States
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
Almatica Pharma firmographics
Firmographics- Name
- Almatica Pharma
- Legal name
- Almatica Pharma LLC
- Website
- https://almatica.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Ownership category
- akta.pro rank
Almatica Pharma industry classification
Industry- Product category
- Specialty Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Neurology & CNS Specialty Pharmaceuticals (HLAIACAC)
- akta.pro secondary industry
- Specialty Care Pharmaceuticals (HLAIAAAB)
Keywords
Where Almatica Pharma is headquartered
LocationHeadquarters
- HQ city
- Morristown
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Almatica Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Others
Revenue model
- Pharmaceutical product sales: Almatica generates revenue through the sale of prescription pharmaceutical products in the CNS (psychiatry and neurology) therapeutic areas, as well as established products covering pain management, neurology, anti-infectives, and cardiovascular diseases.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Almatica Pharma product offering
Product offeringCore offering
Almatica Pharma is a specialty pharmaceutical company that develops, acquires, and commercializes prescription medications focused on the central nervous system (CNS) therapeutic areas of psychiatry and neurology. The company operates two product portfolios: a CNS portfolio (including Escitalopram, Loreev XR, Sertraline, Citalopram, Venlafaxine, and Zolpidem) and an established products portfolio covering pain management (Gralise), anti-infectives (Macrobid, Macrodantin), and cardiovascular diseases (Zestoretic). Almatica also maintains a development pipeline of CNS candidates targeting depression, bipolar disorder, and anxiety.
Product overview
Almatica Pharma is a specialty pharmaceuticals company and subsidiary of Alvogen, focused on developing innovative medicines within the CNS (central nervous system) therapeutic area covering psychiatry and neurology. The company operates two product portfolios: (1) A CNS portfolio consisting of mental health and neurologic medications including Escitalopram, Loreev XR, Sertraline, Citalopram, Venlafaxine, and Zolpidem; and (2) An established products portfolio covering pain management (Gralise), anti-infectives (Macrobid, Macrodantin), and cardiovascular diseases (Zestoretic). The company maintains a pipeline of CNS candidates including ALM003, ALM008, ALM009, ALM013, and ALM014 targeting depression, bipolar disorder, and anxiety conditions. Patient support includes copay savings programs for several products.
Differentiator
Problem solved
Functional benefit
Products and services
- Escitalopram Escitalopram is an SSRI antidepressant medication for the treatment of mental health conditions including depression and anxiety. The product carries a Boxed Warning and is available by prescription through the dedicated product website.
- Loreev XR Loreev XR (lorazepam) is an extended-release capsule medication indicated for mental health conditions, specifically anxiety disorders. The product carries a Boxed Warning and is available by prescription.
- Sertraline Sertraline HCl capsules are an SSRI antidepressant medication for the treatment of mental health conditions including depression, anxiety, and related disorders. The product carries a Boxed Warning.
- Citalopram Citalopram is an SSRI medication used for the treatment of mental health and neurologic conditions. The product carries a Boxed Warning and is available by prescription.
- Venlafaxine Venlafaxine is an SNRI antidepressant medication indicated for the treatment of mental health and neurologic conditions including depression and anxiety disorders. The product carries a Boxed Warning.
- Zolpidem Zolpidem is a sedative-hypnotic medication indicated for the treatment of sleep and neurologic conditions such as insomnia. The product carries a Boxed Warning.
- Gralise Gralise (gabapentin) is an oral tablet medication indicated for pain management, specifically for the management of postherpetic neuralgia. Available by prescription.
- Macrobid Macrobid (nitrofurantoin monohydrate/macrocrystals) 100 mg capsules are an anti-infective medication indicated for the treatment of urinary tract infections. NDC: 52427-285-01.
- Macrodantin Macrodantin (nitrofurantoin macrocrystals) capsules are an anti-infective medication available in 25 mg, 50 mg, and 100 mg strengths for the treatment of urinary tract infections.
- Zestoretic Zestoretic (lisinopril and hydrochlorothiazide) is a cardiovascular combination medication available in 10 mg-12.5 mg, 20 mg-12.5 mg, and 20 mg-25 mg strengths for the treatment of hypertension. The product carries a Boxed Warning.
Companies that use Almatica Pharma
Customer profileSegments2 records
Ideal customer profiles3 records
Almatica Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Almatica Pharma partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- AlvogencoreAlmatica is a subsidiary of Alvogen. The company operates as Alvogen's specialty pharmaceuticals subsidiary focused on innovative medicines in psychiatry and neurology. Alvogen's CEO Divya Patel was appointed as CEO of Almatica in January 2026.
Scale indicators1 record
Recent moves5 records
Expansion highlights4 records
Almatica Pharma competitors and assessment
Company assessmentDirect peers
- Upsher-Smith: US-based specialty generics pharma with a meaningful CNS/neurology portfolio, comparable in scale and go-to-market to Almatica. Both target psychiatrists and neurologists with branded and generic CNS products distributed through US pharmacy channels.
- Supernus Pharmaceuticals: Specialty pharma focused on CNS disorders including ADHD, epilepsy, and depression. Comparable to Almatica's CNS specialty positioning and overlap on psychiatry/neurology prescribing audiences.
- Jazz Pharmaceuticals: Specialty pharma with a portfolio anchored in CNS/neurology indications including psychiatry and neurology. Comparable therapy-area focus and US specialty distribution model to Almatica.
- Amneal Pharmaceuticals: US-focused specialty and generic pharma with significant CNS presence across neurology and psychiatry. Directly comparable hybrid specialty/generic model and similar product mix to Almatica.
- Lannett: US generic pharmaceutical manufacturer with a portfolio that includes CNS and other therapeutic categories. Comparable generic-pharma model with US distribution and similar institutional customer base.
- Apotex: Canadian-headquartered generic pharmaceutical manufacturer with US operations selling into comparable pharmacy distribution channels. Comparable generics business model with overlapping CNS and adjacent therapeutic categories.
Broad incumbents
- Teva Pharmaceutical Industries: World's largest generic drug manufacturer with a broad CNS portfolio including neurology and psychiatry products. Overlaps with Almatica's generic CNS franchise but operates at significantly larger scale across many therapeutic areas.
- Viatris: Global generics and specialty pharma (formed from Mylan/Pfizer Upjohn) with significant CNS franchise. Comparable generic-and-specialty pharma positioning but with vastly broader geographic and therapeutic footprint than Almatica.
- Sandoz: Novartis's generics and biosimilars division with a sizable CNS portfolio and global manufacturing scale. Comparable generics business model but operates at significantly broader scale and therapeutic breadth than Almatica.
- Bausch Health: Diversified specialty pharma with neurology and broader CNS exposure (Salix, Bausch + Lomb). Comparable specialty pharma go-to-market and overlap on US prescriber channels, though at substantially larger scale and breadth.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Almatica Pharma social profiles
Digital presenceAlmatica Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Almatica Pharma leadership team
Management profileNumber of profiles
Profiles2 records
Almatica Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Almatica Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Almatica Pharma
What does Almatica Pharma do?
Almatica Pharma is a specialty pharmaceutical company that develops, acquires, and commercializes prescription medications focused on the central nervous system (CNS) therapeutic areas of psychiatry and neurology. The company operates two product portfolios: a CNS portfolio (including Escitalopram, Loreev XR, Sertraline, Citalopram, Venlafaxine, and Zolpidem) and an established products portfolio covering pain management (Gralise), anti-infectives (Macrobid, Macrodantin), and cardiovascular diseases (Zestoretic). Almatica also maintains a development pipeline of CNS candidates targeting depression, bipolar disorder, and anxiety.
Is Almatica Pharma a public or private company?
Almatica Pharma is a private company. It is classified as corporate owned and is currently operating.
When was Almatica Pharma founded?
Almatica Pharma was founded in 2009. It employs 251 to 500 people.
Where is Almatica Pharma based?
Almatica Pharma is headquartered in Morristown, United States, in the North America region.
How does Almatica Pharma make money?
One revenue line is on record: pharmaceutical product sales.
Who are Almatica Pharma's main competitors?
Direct peers on record are Upsher-Smith, Supernus Pharmaceuticals, Jazz Pharmaceuticals, Amneal Pharmaceuticals, Lannett and Apotex. Broad incumbents are Teva Pharmaceutical Industries, Viatris, Sandoz and Bausch Health.
Does Almatica Pharma have an API?
No public API is recorded for Almatica Pharma.
What industry is Almatica Pharma in?
Almatica Pharma's product category is Specialty Pharmaceuticals. Its primary akta.pro industry code is HLAIACAC, Neurology & CNS Specialty Pharmaceuticals, with a secondary code of HLAIAAAB, Specialty Care Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.